BlissBio
About:
Bliss Bio is a biopharmaceutical company focused on development of tumor targeting and immunotherapy drugs.
Website: http://www.blissbiopharma.com
Top Investors: Cormorant Asset Management, Oriental Fortune Capital, Hillhouse Ventures, Sherpa Healthcare Partners, VMS Asset Management
Description:
Bliss Bio is a biopharmaceutical company focused on development of tumor targeting and immunotherapy drugs.
Total Funding Amount:
500M CNY
Headquarters Location:
Hangzhou, Zhejiang, China
Founded Date:
2017-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-01-18
IPO Status:
Private
Industries:
© 2025 bioDAO.ai